As humanity continues to wage war against cancer, a new ally has been identified in this battle: the humble olive oil. A recent study as part of the Moli-sani Study, which dug into the diet of 11,442 Italian women, has unveiled that increased consumption of olive oil significantly slashes the risk of hormone receptor-negative breast cancer, specifically the estrogen receptor (ER)-negative subtype. This may represent a significant step forward in our understanding of diet’s role in breast cancer prevention, given that this aggressive subtype has typically been more challenging to treat.
While olive oil has long been hailed for its cardiovascular benefits, lauded for its concentration of monounsaturated fat and polyphenols, its potential role in cancer prevention has been a nebulous area. This new research, published in the European Journal of Cancer, led by Emilia R., provides a beacon of clarity, unveiling olive oil as a potential protective agent against the more aggressive forms of breast cancer.
Breast cancer remains the leading cause of cancer death among women globally, making these findings even more crucial. Researchers, driven by the health benefits attributed to the Mediterranean diet, sought to ascertain whether olive oil, a cornerstone of this diet, could wield a positive influence over breast cancer risk. The Moli-sani Study, a large cohort study conducted from 2005-2010, zeroed in on adult women’s dietary patterns and monitored the incidence of breast cancer using Cox proportional hazard models.
This study dovetailed with a systematic review drawing from databases such as Scopus, EMBASE, PubMed, and MEDLINE, which culls from observational studies and randomized controlled trials up to October 2024. The primary goal was to pool and juxtapose results from varying study designs to glean a deeper understanding of olive oil’s interaction with breast cancer risk.
The findings were striking. Women who consumed more than three tablespoons of olive oil per day witnessed a 29% reduced risk of total breast cancer compared to those consuming less or equal to two tablespoons daily. For postmenopausal women, the risk was similarly reduced by 30%. Although the benefit for premenopausal women was not statistically significant, potential benefits were indicated.
The implication of these findings is profound, as it underscores the importance of dietary factors in mitigating the risk of certain types of breast cancer. It also aligns with the broader trend in the healthcare industry to focus on preventive methods and lifestyle modifications. This study also emphasizes the critical role bioengineers and biotech companies can play in nutrition research and its connection to disease prevention. In a world where we are constantly seeking novel solutions to age-old problems, sometimes, the answer lies in the simple, everyday choices we make, such as our diet.
Read more from medicaldialogues.in
